Health, Medical & Pharma News - Updated Daily page 410

Pounds Return Once Zepbound Users Quit the Weight-Loss Drug: Study

Folks who take the blockbuster weight-loss med tirzepatide (Zepbound) may regain much of the weight they lost soon after discontinuing it, new research shows. A

Black Patients Less Likely to Get Home Health Care After Hospital Discharge

Nurses are less likely to discharge still-recovering Black patients to home health care than white patients, a new study has found.About 22 of Black patients ar

Pediatricians' Group Offers Parents Advice on GMO Foods

and there are many nourishing options. More informationThe U.S. Food and Drug Administration has more about GMO foods.SOURCE American Academy of Pediatrics, new

Swift Use of Antiretrovirals in Infected Newborns Can Banish HIV

within 48 hours of birth. The babies mothers had not received antiretroviral meds during their pregnancy.Another group ( group 2 ) of 20 newborns got the same t

Brain Serotonin Levels May Play Role in Alzheimer's Onset

Loss of the happiness brain hormone serotonin might play a role in the decline of brain function as a person ages, a new study reports.People with mild cognitiv

Over 3 Million Americans Struggle With Chronic Fatigue Syndrome

Chronic fatigue syndrome strikes more Americans than many might think In a first national estimate, new government data puts that number at 3.3 million.The cond

First-ever approval of a CRISPR-based gene-editing therapy in the U.S., Casgevy (exagamglogene autotemcel) for the Treatment of Sickle Cell Disease

– Approximately 16,000 patients 12 years of age and older with severe sickle cell disease may now be eligible for this one-time treatment – Multiple authorized treatment centers activated

First Gene-Editing Therapies for Sickle Cell Disease, Casgevy and Lyfgenia, Approved by FDA

Two milestone gene therapies for sickle cell disease have been approved by the U.S. Food and Drug Administration. Casgevy is the first medicine available in the

First-ever approval of a CRISPR-based gene-editing therapy in the U.S.